Influence of pregnancy on neuromyelitis optica spectrum disorder.
about
A treatment of neuromyelitis optica (Devic's disease) during pregnancyImmunology of neuromyelitis optica during pregnancyTreatment of neuromyelitis optica: state-of-the-art and emerging therapiesMOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeClinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.Neuromyelitis optica: clinical features, immunopathogenesis and treatment.Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.Neuromyelitis optica IgG causes placental inflammation and fetal death.On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica.Current options for the treatment of optic neuritis.Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.Sex and gender issues in multiple sclerosis.Spontaneous Recovery of Neuromyelitis Optica Spectrum Disorder during Pregnancy.Postpartum Anti-N-methyl-D-aspartate Receptor Encephalitis: A Case Report and Literature Review.Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study.Neuromyelitis optica spectrum disorders.Multiple sclerosis and pregnancy in the 'treatment era'.Therapeutic options in neuromyelitis optica spectrum disorders.Neuromyelitis optica and pregnancy.High risk of postpartum relapses in neuromyelitis optica spectrum disorder.Neuromyelitis optica and pregnancy.Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum.Postnatal outcome and placental blood flow after plasmapheresis during pregnancy.Relapse of neuromyelitis optica associated with oral progestin.Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management.
P2860
Q28067384-62C4652B-0731-4857-8BAC-F9BBA03E364BQ28078470-760D3EB3-FB83-438D-A169-34211EF1F539Q28245749-BB115F9B-7335-4776-BD3D-2A84CBB8A2FFQ30371412-59180D83-352E-40D0-8357-FA9497ECAD93Q30676331-A09C3B3F-CC2C-4B5D-B38B-8EE29F3D2CC9Q30785267-0A909034-917B-4FFB-94BB-2F687BAB5B8FQ30975717-B660D2F8-1B6B-4F59-87A7-5792734682E0Q34168084-2CBE3EEE-69A2-4C15-98C3-2A77A6B213C5Q34287184-DDA20425-02CB-468D-BF21-9B6C9AD547A0Q36173222-AABA1E3A-AA8B-4F68-ACCF-2EA0A9BDD247Q36515512-11FCCA13-3141-4BBD-A5A2-868A426B0339Q36999743-44B4D39C-46D1-44C3-9DC9-737992DA20FAQ37439444-A093C824-B874-4E58-8313-B4538CB58BA8Q37697293-DA322F02-76A0-46BA-B2A1-EC7972AA2E0FQ37721393-7A308656-61A9-4BDD-8555-44FAF7446C2CQ38229823-04C4C560-530F-42AF-9E19-FF9EF07900CAQ38431744-78D4709B-B614-4392-BE8E-62887A91CD9FQ38721559-5DF54706-58A4-401E-AA94-8EDAE7F3090EQ38866313-CB3425E2-979F-4EFE-85A1-4D89F8A24AAAQ46160275-E55324EF-0AF0-49B0-9240-393173598D2EQ46800143-B926FF57-3F41-433E-B2E1-3700D20CCC8FQ46983280-01BF57C7-5EEE-4477-9DE1-185D17322C42Q48177205-AAF97D08-188F-4C1A-BB93-13081553902CQ48219801-6D308EA7-55B7-4648-8B9D-09F1442A4858Q49873825-2D2DC2D1-0DD8-4DFF-B108-79315593ACDE
P2860
Influence of pregnancy on neuromyelitis optica spectrum disorder.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Influence of pregnancy on neuromyelitis optica spectrum disorder.
@en
Influence of pregnancy on neuromyelitis optica spectrum disorder.
@nl
type
label
Influence of pregnancy on neuromyelitis optica spectrum disorder.
@en
Influence of pregnancy on neuromyelitis optica spectrum disorder.
@nl
prefLabel
Influence of pregnancy on neuromyelitis optica spectrum disorder.
@en
Influence of pregnancy on neuromyelitis optica spectrum disorder.
@nl
P2093
P50
P1433
P1476
Influence of pregnancy on neuromyelitis optica spectrum disorder.
@en
P2093
Byoung-Joon Kim
Byung-Jo Kim
E Coutinho
K Fujihara
P304
P356
10.1212/WNL.0B013E318250D812
P407
P577
2012-04-04T00:00:00Z